Search by Title Article Topic - Any -AdvocacyAnnual Scientific MeetingAwardsBoard Certification ReviewCertificationClinical DocumentClinical TrialsCoronavirusEarly CareerFellowshipFuture LeadersHeart Failure Awareness 365Heart Failure GuidelinesHF Research FoundationHFSA CommitteesHFSA Comprehensive Heart Failure ReviewHFSA Learning CenterIn The NewsIndustryJournal of Cardiac FailureLeadershipMembershipMentorshipNursingPartnersPatient ResourcePatient StoryPodcastsPresident's UpdatesPress ReleaseProfessional DevelopmentProvider EducationResearchSocial MediaStatementSubmissionsWomen in Heart Failure Article Type - Any -HFSA NewsIndustry NewsPatient NewsPractice News Aug 8 2024 | Lifetime Achievement Award Spotlight: Mandeep R. Mehra, MBBS, MSc, FRCP HFSA News Annual Scientific Meeting Awards Read More Aug 8 2024 | Transforming to Patient-Centered and Consumer-Driven Healthcare Announced as Topic for Keynote Session at HFSA Annual Scientific Meeting 2024 HFSA News Annual Scientific Meeting Press Release Read More Aug 5 2024 | Bayer Announces Primary Endpoint Achieved in Phase III FINEARTS-HF Cardiovascular Outcomes Study Investigating KERENDIA® (finerenone) in Patients with Heart Failure with Mildly Reduced or Preserved Ejection Fraction Industry News In The News Industry Read More Aug 2 2024 | SURVEY: Guideline-Directed Medical Therapy Use for Heart Failure in Adult Congenital Heart Disease Practice News Research Read More Aug 1 2024 | Welcoming July's New HFSA Members HFSA News Membership Read More Pagination First page « First Previous page ‹ Previous … Page 29 Page 30 Page 31 Page 32 Current page 33 Page 34 Page 35 Page 36 Page 37 … Next page Next › Last page Last »
Aug 8 2024 | Lifetime Achievement Award Spotlight: Mandeep R. Mehra, MBBS, MSc, FRCP HFSA News Annual Scientific Meeting Awards Read More
Aug 8 2024 | Transforming to Patient-Centered and Consumer-Driven Healthcare Announced as Topic for Keynote Session at HFSA Annual Scientific Meeting 2024 HFSA News Annual Scientific Meeting Press Release Read More
Aug 5 2024 | Bayer Announces Primary Endpoint Achieved in Phase III FINEARTS-HF Cardiovascular Outcomes Study Investigating KERENDIA® (finerenone) in Patients with Heart Failure with Mildly Reduced or Preserved Ejection Fraction Industry News In The News Industry Read More
Aug 2 2024 | SURVEY: Guideline-Directed Medical Therapy Use for Heart Failure in Adult Congenital Heart Disease Practice News Research Read More
